These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 31648513)

  • 1. The relationship between serum NT-proBNP levels and severity of coronary artery disease assessed by SYNTAX score in patients with acute myocardial infarction.
    Sarak T; Karadeniz M
    Turk J Med Sci; 2019 Oct; 49(5):1366-1373. PubMed ID: 31648513
    [TBL] [Abstract][Full Text] [Related]  

  • 2. N-Terminal Pro-Brain Natriuretic Peptide Level is Associated With Severity and Complexity of Coronary Atherosclerosis in Patients With Acute Coronary Syndrome.
    Kurtul A; Yarlioglues M; Murat SN; Duran M; Acikgoz SK; Sensoy B; Ergun G; Cetin M; Ornek E
    Clin Appl Thromb Hemost; 2016 Jan; 22(1):69-76. PubMed ID: 24989712
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NT-proBNP is associated with SYNTAX score and aortic distensibility in patients with stable CAD.
    Sahin DY; Gür M; Elbasan Z; Koyunsever NY; Türkoğlu C; Akyol S; Yıldırım A; Gözübüyük G; Ozaltun B; Caylı M
    Herz; 2013 Dec; 38(8):922-7. PubMed ID: 23483221
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of Coronary Atherosclerosis and Myocardial Ischemia on Plasma Levels of High-Sensitivity Troponin T and NT-proBNP in Patients With Stable Angina.
    Caselli C; Prontera C; Liga R; De Graaf MA; Gaemperli O; Lorenzoni V; Ragusa R; Marinelli M; Del Ry S; Rovai D; Giannessi D; Aguade-Bruix S; Clemente A; Bax JJ; Lombardi M; Sicari R; Zamorano J; Scholte AJ; Kaufmann PA; Knuuti J; Underwood SR; Clerico A; Neglia D
    Arterioscler Thromb Vasc Biol; 2016 Apr; 36(4):757-64. PubMed ID: 26868212
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [N-terminal pro-brain natriuretic peptide (NT-proBNP) and ischemia modified albumin (IMA) in exercise induced ischemia in patients with stable coronary artery disease].
    Piechota WN; Wierzbowski R; Piechota WT; Bejm J; Gielerak G
    Pol Arch Med Wewn; 2006 Jul; 116(1):640-7. PubMed ID: 17340970
    [TBL] [Abstract][Full Text] [Related]  

  • 6. N-terminal pro-B-type natriuretic peptide level is depressed in patients with significant coronary artery disease who have high body mass index.
    Hong SN; Ahn Y; Yoon NS; Moon JY; Kim KH; Hong YJ; Park HW; Kim JH; Jeong MH; Cho JG; Park JC; Kang JC
    Int Heart J; 2008 Jul; 49(4):403-12. PubMed ID: 18753724
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epicardial fat thickness in stable coronary artery disease: its relationship with high-sensitive cardiac troponin T and N-terminal pro-brain natriuretic peptide.
    Börekçi A; Gür M; Özaltun B; Baykan AO; Harbalioğlu H; Seker T; Sen Ö; Acele A; Gözükara MY; Kuloğlu O; Koç M; Çayli M
    Coron Artery Dis; 2014 Dec; 25(8):685-90. PubMed ID: 25004239
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interrelationship in the prognostic efficacy of regional coronary flow reserve, fractional flow reserve, high-sensitivity cardiac troponin-I and NT-proBNP in patients with stable coronary artery disease.
    Hamaya R; Yonetsu T; Kanaji Y; Usui E; Hoshino M; Hada M; Kanno Y; Murai T; Lee T; Kakuta T
    Heart Vessels; 2019 Mar; 34(3):410-418. PubMed ID: 30229410
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The severity of coronary artery disease and reversible ischemia revealed by N-terminal pro-brain natriuretic peptide in patients with unstable angina and preserved left ventricular function.
    Xu L; Qian W; Li W; Liu J; He H; Li G; Cao Y; Yu Y
    Peptides; 2014 Feb; 52():143-8. PubMed ID: 24412773
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pcsk9 is associated with severity of coronary artery lesions in male patients with premature myocardial infarction.
    Gao J; Yang YN; Cui Z; Feng SY; Ma J; Li CP; Liu Y
    Lipids Health Dis; 2021 May; 20(1):56. PubMed ID: 34044829
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of NT-proBNP and multiple biomarkers with severity of angiographic coronary artery disease in diabetic and pre-diabetic Chinese patients.
    Fang Z; Zhou L; Bao Y; Ding W; Shi H; Luo X; Hu R
    PLoS One; 2011; 6(8):e22563. PubMed ID: 21857933
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dynamic changes in N-terminal pro-brain natriuretic peptide in acute coronary syndromes treated with percutaneous coronary intervention: a marker of ischemic burden, reperfusion and outcome.
    Buchner S; Debl K; Barlage S; Griese D; Fredersdorf S; Jeron A; Lubnow M; Müller T; Muders F; Holmer S; Riegger GA; Luchner A
    Clin Chem Lab Med; 2010 Jun; 48(6):875-81. PubMed ID: 20441480
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictive value of NT-proBNP for 30-day mortality in patients with non-ST-elevation acute coronary syndromes: a comparison with the GRACE and TIMI risk scores.
    Schellings DA; Adiyaman A; Dambrink JE; Gosselink AM; Kedhi E; Roolvink V; Ottervanger JP; Van't Hof AW
    Vasc Health Risk Manag; 2016; 12():471-476. PubMed ID: 27920547
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coronary collateral circulation in patients with chronic coronary total occlusion; its relationship with cardiac risk markers and SYNTAX score.
    Börekçi A; Gür M; Şeker T; Baykan AO; Özaltun B; Karakoyun S; Karakurt A; Türkoğlu C; Makça I; Çaylı M
    Perfusion; 2015 Sep; 30(6):457-64. PubMed ID: 25358476
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sensitive cardiac troponins and N-terminal pro-B-type natriuretic peptide in stable coronary artery disease: correlation with left ventricular function as assessed by myocardial strain.
    Smedsrud MK; Gravning J; Omland T; Eek C; Mørkrid L; Skulstad H; Aaberge L; Bendz B; Kjekshus J; Edvardsen T
    Int J Cardiovasc Imaging; 2015 Jun; 31(5):967-73. PubMed ID: 25788439
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Usefulness of N-terminal Pro-brain Natriuretic Peptide and Myocardial Perfusion in Asymptomatic Adults (from the Multi-Ethnic Study of Atherosclerosis).
    Mitchell A; Misialek JR; Folsom AR; Duprez D; Alonso A; Jerosch-Herold M; Sanchez OA; Watson KE; Sallam T; Konety SH
    Am J Cardiol; 2015 May; 115(10):1341-5. PubMed ID: 25816778
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NT-probrain natriuretic peptide predicts complexity and severity of the coronary lesions in patients with non-ST-elevation acute coronary syndromes.
    Navarro Estrada JL; Rubinstein F; Bahit MC; Rolandi F; Perez de Arenaza D; Gabay JM; Alvarez J; Sarmiento R; Rojas Matas C; Sztejfman C; Tettamanzi A; de Miguel R; Guzman L;
    Am Heart J; 2006 May; 151(5):1093.e1-7. PubMed ID: 16644341
    [TBL] [Abstract][Full Text] [Related]  

  • 18. N-terminal probrain natriuretic peptide in patients with acute coronary syndrome
.
    Kang Q; Wan Z; Huang Z
    Int J Clin Pharmacol Ther; 2017 Jan; 55(1):78-84. PubMed ID: 27879192
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Limited utilities of N-terminal pro B-type natriuretic peptide and other newer risk markers compared with traditional risk factors for prediction of significant angiographic lesions in stable coronary artery disease.
    Peer A; Falkensammer G; Alber H; Kroiss A; Griesmacher A; Ulmer H; Pachinger O; Mair J
    Heart; 2009 Feb; 95(4):297-303. PubMed ID: 18708421
    [TBL] [Abstract][Full Text] [Related]  

  • 20. N-terminal pro B-type natriuretic peptide in the early evaluation of suspected acute myocardial infarction.
    Haaf P; Balmelli C; Reichlin T; Twerenbold R; Reiter M; Meissner J; Schaub N; Stelzig C; Freese M; Paniz P; Meune C; Drexler B; Freidank H; Winkler K; Hochholzer W; Mueller C
    Am J Med; 2011 Aug; 124(8):731-9. PubMed ID: 21787902
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.